Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132023) titled 'Feasibility Study of Kaiser Score Combined with Apparent Diffusion Coefficient in the Diagnosis of Nonmass Enhancement Lesions of the Breast' on Sept. 9.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The Eighth People's Hospital of Jinan
Condition:
Breast nonmass enhancement lesions, benign and malignant breast lesions
Intervention:
Gold Standard:Histopathological diagnosis obtained after surgical resection or needlecore biopsy serves as the gold standard for judging benign or malignant breast nonmassenhancing lesions.
Recruitment Status: Not Recruiting
Phase: ...